L. Uller (Lund, Sweden), I. Adcock (London, United Kingdom)
Inhaled corticosteroid (ICS) induced metabolome changes in asthmatics.
P. Daley-Yates (Uxbridge, United Kingdom), B. Keppler (Morrisville, United States of America), N. Brealey (Uxbridge, United Kingdom), S. Shabbir, (Stevenage, United Kingdom), D. Singh (Manchester, United Kingdom), N. Barnes (Brentford, United Kingdom)
|     |
Azithromycin prevents airway epithelial barrier dysfunction induced by sulphur dioxide inhalation
J. Kricker (REYKJAVIK, Iceland), T. Gudjonsson (REYKJAVIK, Iceland), A. Arason (REYKJAVIK, Iceland), J. Joelsson (REYKJAVIK, Iceland), B. Valdimarsdottir (REYKJAVIK, Iceland), F. Gardarsson (REYKJAVIK, Iceland), C. Page (LONDON, United Kingdom), F. Lehmann (REYKJAVIK, Iceland), S. Ingthorsson (REYKJAVIK, Iceland)
| |
Changes in DNA methylation after corticosteroids treatment in COPD patients
J. van Nijnatten (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), P. Hiemstra (Leiden, Netherlands), W. Timens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), A. Faiz (Sydney, Australia)
| |
PBF-680, an oral A1 adenosine receptor antagonist, inhibits the late allergic response (LAR) in mild-to-moderate atopic asthmatics: a Phase-IIa trial
D. Ramos-Barbon (Barcelona, Spain), N. Brienza (Barcelona, Spain), T. Bigorra Rodríguez (Barcelona, Spain), É. Mateus Medina (Barcelona, Spain), I. Gich Saladich (Barcelona, Spain), M. Puntes Rodríguez (Barcelona, Spain), R. Antonijoan Arbos (Barcelona, Spain), S. Quirce Gancedo (Madrid, Spain), N. Castro Palomino Laria (Barcelona, Spain), J. Castro Palomino Laria (Barcelona, Spain)
| |
PGE2 and PGI2 restore defective lung epithelial progenitors induced by cigarette smoke
X. Wu (Groningen, Netherlands), S. Bos (Groningen, Netherlands), L. Verkleij (Groningen, Netherlands), A. D’Ambrosi (Groningen, Netherlands), M. Schmidt (Groningen, Netherlands), L. Kiestemaker (Groningen, Netherlands), R. Gosens (Groningen, Netherlands)
| |
Ensifentrine, a dual PDE3/PDE4 inhibitor, improves FEV1 regardless of smoking status or history of chronic bronchitis
T. Rheault (London, United Kingdom), T. Bengtsson (Lund, Sweden), K. Rickard (London, United Kingdom)
| |